As of 2025-03-21, the Relative Valuation of Biovaxys Technology Corp (BIOV.CN) is (0.00) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.05 CAD, the upside of Biovaxys Technology Corp based on Relative Valuation is -101.7%.
The range of the Relative Valuation is (0.00) - (0.00) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.00) - (0.00) | (0.00) |
| Upside | -101.3% - -102.0% | -101.7% |
| Date | P/E |
| 2025-03-07 | -2.99 |
| 2025-03-06 | -2.99 |
| 2025-03-05 | -2.69 |
| 2025-03-04 | -2.69 |
| 2025-03-03 | -2.99 |
| 2025-02-28 | -3.29 |
| 2025-02-27 | -3.29 |
| 2025-02-26 | -2.99 |
| 2025-02-25 | -3.59 |
| 2025-02-24 | -3.29 |
| 2025-02-21 | -3.29 |
| 2025-02-20 | -2.99 |
| 2025-02-19 | -3.29 |
| 2025-02-18 | -2.99 |
| 2025-02-14 | -2.69 |
| 2025-02-13 | -2.69 |
| 2025-02-12 | -2.99 |
| 2025-02-11 | -2.99 |
| 2025-02-10 | -3.29 |
| 2025-02-07 | -3.29 |
| 2025-02-06 | -3.29 |
| 2025-02-05 | -2.99 |
| 2025-02-04 | -3.59 |
| 2025-02-03 | -3.29 |
| 2025-01-31 | -3.59 |
| 2025-01-30 | -3.59 |
| 2025-01-29 | -3.59 |
| 2025-01-28 | -3.59 |
| 2025-01-27 | -3.59 |
| 2025-01-24 | -3.59 |
| 2025-01-23 | -3.59 |
| 2025-01-22 | -3.29 |
| 2025-01-21 | -3.29 |
| 2025-01-20 | -3.59 |
| 2025-01-17 | -3.89 |
| 2025-01-16 | -3.59 |
| 2025-01-15 | -3.59 |
| 2025-01-14 | -3.59 |
| 2025-01-13 | -3.29 |
| 2025-01-10 | -3.59 |
| 2025-01-09 | -3.89 |
| 2025-01-07 | -3.59 |
| 2025-01-06 | -3.59 |
| 2025-01-03 | -3.89 |
| 2025-01-02 | -3.59 |
| 2024-12-31 | -3.59 |
| 2024-12-30 | -3.29 |
| 2024-12-27 | -3.89 |
| 2024-12-24 | -3.89 |
| 2024-12-23 | -3.89 |